nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antitumour activity and schedule dependency of 8-chloroadenosine-3′,5′-monophosphate (8-ClcAMP) against human tumour xenografts
|
Langdon, S.P. |
|
1998 |
34 |
3 |
p. 384-388 |
artikel |
2 |
BRCA1-Positive patients are small for gestational age compared with their unaffected relatives
|
Jernström, H |
|
1998 |
34 |
3 |
p. 368-371 |
artikel |
3 |
Commentary
|
Pinkerton, C.R. |
|
1998 |
34 |
3 |
p. 362-363 |
artikel |
4 |
comments on: Haemostatic abnormalities in lung cancer: prognostic implications, Buccheri et al., Eur J Cancer, 33, pp. 50–55, 1997
|
Watine, J |
|
1998 |
34 |
3 |
p. 430 |
artikel |
5 |
Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer
|
van Laar, J.A.M. |
|
1998 |
34 |
3 |
p. 296-306 |
artikel |
6 |
Dipeptidyl peptidase III in malignant and non-malignant gynaecological tissue
|
Šimaga, Š |
|
1998 |
34 |
3 |
p. 399-405 |
artikel |
7 |
Editorial
|
|
|
1998 |
34 |
3 |
p. 353-358 |
artikel |
8 |
Editorial
|
|
|
1998 |
34 |
3 |
p. 277-278 |
artikel |
9 |
Eight-year results of a prospective non-randomised study on therapy of small breast cancer
|
Rauschecker, H.F |
|
1998 |
34 |
3 |
p. 315-323 |
artikel |
10 |
Electronic biomedical journals: how they appear and what they offer
|
Alloro, G |
|
1998 |
34 |
3 |
p. 290-295 |
artikel |
11 |
Human transplacental passage of the retinoid fenretinide (4HPR)
|
Formelli, F |
|
1998 |
34 |
3 |
p. 428-429 |
artikel |
12 |
Identification of a new commonly deleted region within a 2-cM interval of chromosome 11p11 in breast cancers
|
Nakata, T |
|
1998 |
34 |
3 |
p. 417-421 |
artikel |
13 |
Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?
|
Fizazi, K |
|
1998 |
34 |
3 |
p. 347-352 |
artikel |
14 |
Irinotecan and 5-Fluorouracil in colorectal cancer: time for a pause?
|
Bulusu, V.R |
|
1998 |
34 |
3 |
p. 286-289 |
artikel |
15 |
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer
|
Benedetti-Panici, P. |
|
1998 |
34 |
3 |
p. 341-346 |
artikel |
16 |
Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients
|
Oinonen, R. |
|
1998 |
34 |
3 |
p. 329-336 |
artikel |
17 |
α-Melanotropin immunoreactivity in human melanoma exudate is related to necrosis
|
Loir, B |
|
1998 |
34 |
3 |
p. 424-426 |
artikel |
18 |
Non-Hodgkin’s lymphoma
|
Patte, C |
|
1998 |
34 |
3 |
p. 359-362 |
artikel |
19 |
No predictive value of the micronucleus assay for patients with severe acute reaction of normal tissue after radiotherapy
|
Rached, E. |
|
1998 |
34 |
3 |
p. 378-383 |
artikel |
20 |
Pharmacokinetics of cisplatin with and without amifostine in tumour-bearing nude mice
|
Korst, A.E.C. |
|
1998 |
34 |
3 |
p. 412-416 |
artikel |
21 |
Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice
|
Feleszko, W. |
|
1998 |
34 |
3 |
p. 406-411 |
artikel |
22 |
Product review
|
|
|
1998 |
34 |
3 |
p. 427 |
artikel |
23 |
Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801
|
Curran, D |
|
1998 |
34 |
3 |
p. 307-314 |
artikel |
24 |
Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours
|
Csáki, C. |
|
1998 |
34 |
3 |
p. 364-367 |
artikel |
25 |
Results of a phase II trial with second-line cystemustine at 60mg/m2 in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group
|
Curé, H. |
|
1998 |
34 |
3 |
p. 422-423 |
artikel |
26 |
Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity
|
Sánchez-Rovira, P. |
|
1998 |
34 |
3 |
p. 394-398 |
artikel |
27 |
Should cancer patients with incurable disease receive parenteral or enteral nutritional support?
|
Delmore, G |
|
1998 |
34 |
3 |
p. 282-284 |
artikel |
28 |
Should cancer patients with incurable disease receive parenteral or enteral nutritional support?
|
Barber, M.D |
|
1998 |
34 |
3 |
p. 279-282 |
artikel |
29 |
Should cancer patients with incurable disease receive parenteral or enter nutritional support — bridging editorial
|
Loprinzi, C.L |
|
1998 |
34 |
3 |
p. 284-285 |
artikel |
30 |
Survival of breast cancer patients in Lithuania and Norway, 1988–1992
|
Kliukien≐, J |
|
1998 |
34 |
3 |
p. 372-377 |
artikel |
31 |
3,3′,4,4′-Tetrachlorobiphenyl (TCB) can enhance DMBA-induced mammary carcinogenesis in the rat
|
Nesaretnam, K |
|
1998 |
34 |
3 |
p. 389-393 |
artikel |
32 |
The use of complementary therapies by breast cancer patients attending conventional treatment
|
Crocetti, E |
|
1998 |
34 |
3 |
p. 324-328 |
artikel |
33 |
Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma
|
Ellis, L.M. |
|
1998 |
34 |
3 |
p. 337-340 |
artikel |
34 |
Why are patients with malignant lymphomas excluded from clinical trials? The experience of an oncology institute in Italy
|
Serraino, D |
|
1998 |
34 |
3 |
p. 427-428 |
artikel |